← back to search

Mikalai Nienen

Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DE
Area of research
Immunology · Oncology
Research interest
Research interests include T-cell and B-cell Immunology, Immune Cell Function and Interaction, Polyomavirus and related diseases, and Immunotherapy and Immune Responses.
h-index
17
citations
1,923
works
26
NIH funding
primary concept
email

Recent publications

In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder
Kidney International 2022cited by 10position: middledoi
Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity
Molecular Therapy — Methods & Clinical Development 2021cited by 14position: middledoi
SLAMF7 and IL-6R define distinct cytotoxic versus helper memory CD8+ T cells
Nature Communications 2020cited by 74position: middledoi
Propionate supplementation promotes the expansion of peripheral regulatory T-Cells in patients with end-stage renal disease
Journal of Nephrology 2020cited by 34position: middledoi
Association between Subcutaneous Adipose Tissue Inflammation, Insulin Resistance, and Calorie Restriction in Obese Females
The Journal of Immunology 2020cited by 25position: middledoi
T cell receptor repertoires within liver allografts are different to those in the peripheral blood
Journal of Hepatology 2020cited by 24position: middledoi
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Cell 2019cited by 471position: middledoi
BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients
Frontiers in Immunology 2019cited by 30position: middledoi
Differential Diagnosis of Interstitial Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing
Transplantation 2019cited by 7position: middledoi
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Nature Immunology 2018cited by 409position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nina Babel · Universitätsklinik Marien Hospital Herne9 papers (2018–2022)Ulrik Stervbo · University Hospitals of the Ruhr-University of Bochum5 papers (2019–2022)Timm H. Westhoff · Charité - Universitätsmedizin Berlin5 papers (2019–2022)Jochen Hecht · Düsseldorf University Hospital3 papers (2019–2022)Petra Reinke · Humboldt-Universität zu Berlin3 papers (2019–2022)Patrizia Wehler · Humboldt-Universität zu Berlin2 papers (2019–2022)Lèon Kuchenbecker · University of Tübingen2 papers (2019–2020)Frederic Bauer · Charité - Universitätsmedizin Berlin2 papers (2020–2021)Toralf Roch · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2021–2022)Karsten Jürchott · Charité - Universitätsmedizin Berlin2 papers (2020–2020) · 2 papers (2019–2022)Felix S. Seibert · Charité - Universitätsmedizin Berlin2 papers (2020–2021)Regina Stark · Berlin Institute of Health at Charité - Universitätsmedizin Berlin1 papers (2020–2020)Anne-Marie Decker · Humboldt-Universität zu Berlin1 papers (2020–2020)Anna‐Barbara Stittrich · Charité - Universitätsmedizin Berlin1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2020–2020)Heiner Appel · Charité - Universitätsmedizin Berlin1 papers (2021–2021) · 1 papers (2021–2021)Philipp Hemmati · Klinikum Ernst von Bergmann1 papers (2018–2018)